Amgen Inc. v. F. Hoffmann-LaRoche LTD et al

Filing 728

MEMORANDUM in Support re 727 MOTION for Leave to File Under Seal Documents Containing Defendants' Trade Secrets Submitted in Connection with the Pendleton and Galvin Declarations filed by F. Hoffmann-LaRoche LTD, Roche Diagnostics GmbH, Hoffmann LaRoche Inc.. (Attachments: # 1 Exhibit A# 2 Exhibit B# 3 Exhibit C)(Toms, Keith)

Download PDF
Amgen Inc. v. F. Hoffmann-LaRoche LTD et al Doc. 728 Att. 1 Case 1:05-cv-12237-WGY Document 728-2 Filed 07/16/2007 Page 1 of 2 UNITED STATES DISTRICT COURT DISTRICT OF MASSACHUSETTS AMGEN INC., ) ) ) ) ) v. ) Plaintiff, ) I Exhibit A C. A. No.: 05-CV-I2237-WGY F. HOFFMANN-LA ROCHE LTD., ) a Swiss Company, ROCHE ) DIAGNOSTICS GmbH, a German ) Company and HOFFMANN-LA ROCHE ) INC., a New Jersey Corporation, ) ) ) Defendants. ) ) ) PUBLIC VERSION Exhibit 36 to the Declaration of Cullen N. Pendleton in Support of Amgen's Opposition to Roche's Motion for Summary Judgment that Claim 7 of the '349 Patent is Invalid Under 35 USC 112 and is Not Infringed Dockets.Justia.com Case 1:05-cv-12237-WGY Document 728-2 Filed 07/16/2007 Page 2 of 2 423 CONTROL OF MATERIALS IRedacted I IDENTITY OF THE WORKING CELL BANK (WCB) 29.04.93: PHENOTYPIC ANALYSIS 1. SUMMARY Phenotypic propertes of the Working Cell Bank (WCB) 29.04.93 derived Chinese hamster ovary (CHO) cells were analyzed by testing methotrexate (MTX) resistance. The presence of the dihydrofolate reductase (DHFR) gene, correlated to the MTX resistance, was shown in the end-of-production cells (EPC) by their abilty to grow in the presence of MTX. For this purpose CHO cells were harvested I I as EPC from a 10 L-Iaboratory scale fermentation. During this 10 L-Iaboratory scale fermentation the CHO cells were cultivated in the absence of MTX which reflects the full scale fermentation process. The EPC were grown I I I i in spinner flasks without MTX. Then the EPC were split into cultivated for additional I I cycles to evaluate MTX resistance. cultures without and with i I MTX in the medium. The EPC were then Without MTX the specific Epoetin beta (EPO) productivity amounted to about 3.4 .g EPOI1 06 cells/day I I. During furter cultivation without productivity. Thus, in the extended cultivation MTX the specific productivity decreased to about 50 % of the initial specific EPO specific productivity of about 2 .g EPO/1 06 cells! day was found. However in the presence of MTX the specifc productvity remained at a constant level of about ILa 3.7.g EP0l106 cells/day. In respect to growth expressed as doubling times the WCB 29.04.93 derived CHO cells showed the same behavior as the CHO cells used for the serum containing EPO production process. Regarding specific productivity the WCB 29.04.93 derived CHO cells showed in the absence of MTX the same reduction I I of the original specific EPO productivity as the CHO cells used for the serum containing EPO production process. 2. OBJECTIVE The medium for the cultivation of the CHO cells contains no nucleosides. For the biosynthesis of nucleosides the CHO cells have to synthesize appropriate amounts of the enzyme dihydrofolate reductase (DHFR) for cell growt. MTX inhibits the DHFR. Thus, only if the gene coding for DHFR is available in adequate copy numbers the cells can grow in the presence of MTX. The objective of the phenotypic analysis was to prove MTX resistance of WCB 29.04.93 derived CHO cells in extended serum-free culture. Referenc: cm06645 Verion: 1.0 b-Ro.053821_3.2.S.2.3.MA T.wcb.mt 'Pharma Biotechnolog 1/5 Haussm~Dn Anja

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?